Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...
Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback